Chickenpox Clinical Trial
Official title:
Evaluation of Safety and Immunogenicity Receiving Live Attenuated Vaccine Against Varicella Without Gelatin
The purpose of this study is to observe the occurrence of adverse reaction and antibody positive rate, the elevated level of antibody，Geometric mean titer (GMT) between groups of live attenuated varicella vaccine without gelatin.
Observational Objectives:
To describe the safety of evaluated vaccine, in children aged ≥ 1th birthday and ≤ 12th
birthday.
To describe the immunogenicity of evaluated vaccine, in children aged ≥ 1th birthday and ≤
12th birthday.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01887496 -
Varicella-related Hospitalizations in Turkey
|
N/A | |
| Completed |
NCT02570126 -
A Safety and Immune Study of 2 Types of GlaxoSmithKline's Varicella Vaccines Given as a 2-doses Course to Healthy Children 12-23 Months of Age.
|
Phase 3 | |
| Completed |
NCT00326183 -
Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella Virus Vaccine Live Safety Study (V251-066)(COMPLETED)
|
Phase 4 | |
| Completed |
NCT02452229 -
Review of Human Herpes Viruses in Burns
|
N/A | |
| Completed |
NCT01815073 -
Immunogenicity and Safety of Live Attenuated Varicella Vaccine Combined With Live Attenuated JE Vaccine
|
Phase 4 | |
| Completed |
NCT01817270 -
Immunogenicity and Safety Study of 2 Doses of Live Attenuated Varicella Vaccine
|
Phase 4 | |
| Active, not recruiting |
NCT01982409 -
Immune Persistence After Inoculated With One-dose Freeze-Dried Live Attenuated Varicella Vaccine in Children Vaccine in Children
|
Phase 4 | |
| Completed |
NCT00921999 -
Immune Response to Varicella-Zoster Vaccination and Infection
|
N/A | |
| Completed |
NCT00098046 -
Famciclovir Oral Pediatric Formulation in Children 1-12 Years of Age With Varicella Zoster Infection
|
Phase 3 | |
| Completed |
NCT05732337 -
Open Clinical Investigation to Evaluate the Effectiveness and Safety of a Topical Medical Device.
|
N/A | |
| Completed |
NCT00156559 -
MMR and Varicella Vaccine in Premature Infants
|
Phase 4 | |
| Active, not recruiting |
NCT05084508 -
A Study on the Immune Response and Safety of Various Potencies of an Investigational Chickenpox Vaccine Compared With a Marketed Chickenpox Vaccine, Given to Healthy Children 12 to 15 Months of Age
|
Phase 2 | |
| Completed |
NCT04384016 -
Safety and Immunogenicity of Skyvaricella Injection in Healthy Volunteer Vietnamese Children From 12 Months to 12 Years Old
|
Phase 4 | |
| Completed |
NCT00001125 -
Use of a Varicella-Zoster Virus (VZV) Vaccine to Prevent Shingles in HIV-Infected Children Who Have Already Had Chickenpox
|
Phase 1 | |
| Completed |
NCT00000953 -
Comparison of Brovavir Versus Acyclovir in the Treatment of Herpes in HIV-Infected Patients
|
Phase 2 | |
| Completed |
NCT00002315 -
A Comparison of 882C87 Versus Acyclovir in the Treatment of Herpes Zoster in Patients With Weakened Immune Systems
|
Phase 3 | |
| Withdrawn |
NCT00001054 -
The Safety and Effectiveness of Valacyclovir HCl in the Treatment of Herpes Simplex or Varicella/Zoster Infections in HIV-1 Infected Children
|
Phase 1 | |
| Completed |
NCT00002358 -
A Study of BV-araU in the Treatment of Varicella-Zoster Viral Disease (VZV) in HIV-Infected Children Who Have Not Had Success With or Who Cannot Take Other Treatments for VZV
|
Phase 3 |